Skip to content
Screener

Pulse Biosciences, Inc. PLSE Gross margin

Gross margin at other companies

Abbott logo
AbbottABT
56.6%+0.6pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
67.9%0.0pp
Boston Scientific logo
Boston ScientificBSX
69.9%+1.7pp
AtriCure logo
AtriCureATRC
76.3%+1.6pp
Medtronic logo
MedtronicMDT
65%-0.3pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
48.7%+0.9pp

Other financials

Income statement

See full
Revenue$434.0K—
Gross profit$161.0K—
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+156%
Enterprise value$2.55B+173%
P/S2,233.4×—

Profitability

See full
Operating margin-7,007.8%—
Net margin-6,755.8%—
FCF margin-5,180.4%—

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

gross profit/total revenue=-0.1%

Based on trailing twelve months.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288

FAQ

What is Pulse Biosciences, Inc.'s gross margin?
Pulse Biosciences, Inc. (PLSE) reported gross margin of -0.1% in Q2 2026.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.

Ask your AI about Pulse Biosciences, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude